Related Experiment Video
Updated: Jul 6, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
The microbiome-gut-gonad axis: How microbial metabolites orchestrate reproductive physiology, pathology, and therapy
Amr Ali Mohamed Abdelgawwad El-Sehrawy1, Ghaleb Oriquat2, Jasur Rizaev3
1Internal medicine, Diabetes, Endocrinology and Metabolism, Mansoura University, Mansoura, Egypt.
The gut microbiome influences reproductive health via the Microbiome-Gut-Gonad Axis. Microbial metabolites impact reproductive hormones and function, offering potential therapeutic targets for endocrine disorders.
Area of Science:
- Reproductive Endocrinology
- Microbiome Research
- Metabolomics
Background:
- The human microbiome acts as an endocrine organ, influencing systemic functions.
- The Microbiome-Gut-Brain Axis is established, but the Microbiome-Gut-Gonad Axis is an emerging area.
- Gut microbial metabolites play roles in reproductive physiology and endocrine disorder pathogenesis.
Purpose of the Study:
- To construct a comprehensive model of the Microbiome-Gut-Gonad axis.
- To elucidate the mechanistic roles of microbial metabolites in reproductive function and endocrine disorders.
- To critically appraise the potential of microbiome-targeted interventions.
Main Methods:
- Review of cutting-edge evidence from in vitro, animal, and early clinical studies.
- Analysis of microbial metabolites like SCFAs, bile acids, and indole derivatives.
- Examination of mechanisms including epigenetic regulation and aryl hydrocarbon receptor (AhR) signaling.
Main Results:
- Gut-derived molecules modulate the hypothalamic-pituitary-gonadal (HPG) axis, affecting hormone production, steroidogenesis, and gametogenesis.
- Specific mechanisms involve butyrate's epigenetic effects, bacterial modulation of estrogen circulation, and tryptophan metabolites.
- Dysbiosis-driven metabolite shifts are linked to PCOS, endometriosis, and male infertility, with metabolite signatures as candidate biomarkers.
Conclusions:
- The Microbiome-Gut-Gonad axis provides a new framework for understanding reproductive endocrine disorders.
- Microbial metabolite signatures are promising, but require further clinical validation.
- Microbiome-targeted therapies (probiotics, postbiotics, diet) are investigational but hold therapeutic potential.
Related Concept Videos
Gut-Brain Axis
Microbiota Modulation by Antibiotics
Functions of the Gut Microbiota
Introduction to the Human Microbiota
Dysbiosis of the Gut Microbiota
Microbiota of the Urogenital Tract

